--- title: InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023 description: Research presented at IDWeek 2023 highlights role of MIPD to improve patient safety, enhance clinical practice and reduce the costs image: https://blog.insight-rx.com/hubfs/Copy-of-IDWeek-2023-InsightRX-Twitter-Post-2.png --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://blog.insight-rx.com/) - For Providers - Solutions - [MIPD for Providers Explore our full solution for Bayesian model-informed dosing](https://www.insight-rx.com/mipd) - [Future of Pharmacy Learn what's next for AI in health tech, and why architecture matters](https://www.insight-rx.com/future) - Products - [InsightRX Nova Bayesian dosing (MIPD) app for bedside clinical decision support](https://www.insight-rx.com/provider/nova) - [InsightRX Apollo Real-time clinical analytics to measure outcomes](https://www.insight-rx.com/provider/apollo) - [Drug Modules Available medications for precision dosing apps](https://www.insight-rx.com/provider/drug-modules) - [For Life Sciences](https://www.insight-rx.com/life-sciences) - Overview - [InsightRX for Life Sciences Explore our solution for biopharma and clinical trial use](https://www.insight-rx.com/life-sciences) - Products - [Nova for Life Sciences Precision dosing app for clinical trial use](https://www.insight-rx.com/life-sciences/nova) - [Astra for Life Sciences AI-native environment for PK/PD modeling and simulation](https://www.insight-rx.com/life-sciences/astra) - Platform - [Continuous Learning Patented process for model retraining and improvement](https://www.insight-rx.com/platform/continuous-learning) - [Integrations Platform interoperability setup with EHRs, EDCs, and more](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory Standards for product development and release](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support Pharmacist-led training, onboarding, and education](https://www.insight-rx.com/platform/support) - Resources - Science - [Data Science Explore the science and learn more about our R&D](https://www.insight-rx.com/data-science) - [Scientific Publications Impactful research manuscripts with at least one InsightRX author](https://www.insight-rx.com/data-science/scientific-publications) - [How to Cite Using one of our apps? Follow this easy guide for citation in research](https://www.insight-rx.com/how-to-cite-insightrx-nova) - Explore - [Success Stories Case studies from real InsightRX customers about their journey](https://www.insight-rx.com/success-stories) - [White Papers In-depth analysis and best practices for review and download](https://blog.insight-rx.com/resources/tag/white-papers) - [Pubs. Using InsightRX Review research that has used InsightRX applications](https://www.insight-rx.com/publications-using-insightrx-software) - [Blog](https://blog.insight-rx.com/resources) - [All Blog Posts Read the latest posts by our team of experts](https://blog.insight-rx.com/resources) - [Product Innovation The latest updates on our products, services, and science](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership Posts from our team of experts on PK, MIPD, science, and more](https://blog.insight-rx.com/resources?section=thought_leadership) - Company - About - [About Us Our story, what drives us and why we're passionate about our work](https://www.insight-rx.com/about) - [Leadership Founders and team leaders who strive toward excellence in MIPD](https://www.insight-rx.com/leadership) - [Advisory Board Scientists and experts to ensure our collective success](https://www.insight-rx.com/advisory-board) - [Careers Interested in joining? View available openings here](https://www.insight-rx.com/careers) - [Customers Hear what others have to say about their experience](https://www.insight-rx.com/customers) - Press - [All Stories InsightRX news, company updates, and more](https://blog.insight-rx.com/press-releases) - [Press Releases Announcements for events, partnerships, and company updates](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media InsightRX in the news — digital, print, podcasts, and other outlets](https://blog.insight-rx.com/press-releases?section=media) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) Press Releases # InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023 - Published October 4, 2023 By [InsightRX Communications](https://blog.insight-rx.com/press-releases/author/insightrx) ![](https://blog.insight-rx.com/hubfs/Copy-of-IDWeek-2023-InsightRX-Twitter-Post-2.png) SAN FRANCISCO, October 4, 2023 – [InsightRX](https://www.insight-rx.com/) – which provides cloud-based precision medicine software to optimize treatment decisions – today announced that results of several studies analyzing the use of its software for model-informed precision dosing (MIPD) will be presented at IDWeek 2023, October 11-15 in Boston. Three distinct studies aim to spotlight data and analysis of antibiotic therapeutic drug monitoring, highlighting the potential for precision medicine enabled by InsightRX solutions to improve patient safety, enhance clinical practice, and reduce the cost of care. Highly effective antibiotics, such as aminoglycosides and vancomycin, are widely used in hospitals to treat infections, yet they present unique dosing and monitoring challenges for clinicians. Dosing levels outside the target range for individual patients can cause nephrotoxicity, leading to worsening patient conditions, longer hospital stays, and higher costs of care. Nearly a half-million patients are impacted by acute kidney injuries (AKIs) in the U.S. each year, costing the nation’s healthcare system $4.7 billion to $24.0 billion annually, [research](https://journals.sagepub.com/doi/abs/10.1177/0897190019852556) shows. > “We’re thrilled to share our latest research in model-informed precision dosing at IDWeek,” said Sirj Goswami, PhD, CEO and cofounder of InsightRX. “Building upon these results and the numerous other studies we conduct, we hope to improve clinical outcomes and operational efficiency while reducing costs associated with AKIs for health systems.” The InsightRX team will present and host poster sessions focused on precision dosing for the treatment of infectious diseases:   - **“Age and Body Mass Index Impact Optimal Vancomycin Model Selection for Bayesian Dosing: Results from a Large Multi-Site Retrospective Study of Adult Patients”** presented by Maria-Stephanie Hughes, PharmD, Clinical Applications Specialist, and Tiffany Lee, PharmD, Clinical Applications Specialist, InsightRX.   - **“Can Aminoglycoside Dosing Be Improved Through Use of Pharmacokinetic Models from Other Aminoglycosides?”** poster session presented by Jonathan Faldasz, PharmD, BCPS, and Jasmine Hughes, PhD, Director of Data Science, InsightRX.  - **“Multisite Analysis of Vancomycin Predictions in a Bayesian Software in Patients With and Without Acute Kidney Injury in Adult and Pediatric Patients”** poster session presented by Maria-Stephanie Hughes, PharmD, Clinical Applications Specialist, and Jasmine Hughes, PhD, Director of Data Science, InsightRX.  The studies were informed by InsightRX’s cloud-based, AI-powered platform, which equips clinicians with intuitive and efficient tools that expedite the identification and optimization of dosage regimens, simplify report generation, fine-tune best practices, and facilitate continuous policy and protocol improvements.   To learn more, join our [sessions at IDWeek](https://idweek.org/) or [schedule a meeting](https://www.insight-rx.com/conversion/)with the InsightRX team. [vancomycin](https://blog.insight-rx.com/press-releases/tag/vancomycin) [infectious diseases](https://blog.insight-rx.com/press-releases/tag/infectious-diseases) [aminoglycosides](https://blog.insight-rx.com/press-releases/tag/aminoglycosides) [conferences](https://blog.insight-rx.com/press-releases/tag/conferences) [data science](https://blog.insight-rx.com/press-releases/tag/data-science) [IDWeek](https://blog.insight-rx.com/press-releases/tag/idweek) #### On this page… **Connect with us to get the latest blog updates, instantly sent to your inbox** ## Dig deeper. Explore related articles and additional posts on the InsightRX blog. [Media Dec 20, 2021 Using Precision Medicine To Prevent Adverse Drug Events](https://blog.insight-rx.com/press-releases/using-precision-medicine-prevent-adverse-drug-events) [Press Releases Jun 8, 2021 InsightRX’s Precision Medicine Platform Integrated Into Sentara Healthcare EHR To Help Safely Administer Vancomycin Doses For Treatment Of Infections](https://blog.insight-rx.com/press-releases/precision-medicine-platform-integrated-sentara-healthcare-ehr-safely-administer-vancomycin-doses) [Press Releases Dec 13, 2022 InsightRX Provides Máxima Medical Center with Precision Dosing Guidance](https://blog.insight-rx.com/press-releases/insightrx-provides-maxima-medical-center-precision-dosing-guidance) #### What We Do ##### For Providers - [Nova (Bayesian Dosing)](https://www.insight-rx.com/provider/nova) - [Apollo (Clinical Analytics)](https://www.insight-rx.com/provider/apollo) - [Drug Modules](https://www.insight-rx.com/provider/drug-modules) ##### For Life Sciences - [Nova (MIPD for Clinical Trials)](https://www.insight-rx.com/life-sciences/nova) - [Astra (AI-Powered Clin Pharm)](https://www.insight-rx.com/life-sciences/astra) - [Companion Applications](https://www.insight-rx.com/life-sciences/nova#companion-applications) #### How We Do It ##### Platform - [Continuous Learning](https://www.insight-rx.com/platform/continuous-learning) - [Integrations](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support](https://www.insight-rx.com/platform/success-support) ##### Science - [Data Science](https://www.insight-rx.com/data-science) - [Scientific Publications](https://www.insight-rx.com/data-science/scientific-publications) #### Information ##### Resources - [Success Stories](https://www.insight-rx.com/success-stories) - [White Papers](https://www.insight-rx.com/white-papers) - [Publications Using InsightRX](https://www.insight-rx.com/publications-using-insightrx-software) - [How to Cite InsightRX](https://www.insight-rx.com/how-to-cite-insightrx-nova) ##### Blog - [All Posts](https://blog.insight-rx.com/resources) - [Product Innovation](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership](https://blog.insight-rx.com/resources?section=thought_leadership) #### About - [Our Story](https://www.insight-rx.com/about) - [Leadership](https://www.insight-rx.com/leadership) - [Advisory Board](https://www.insight-rx.com/advisory-board) - [Our Customers](https://www.insight-rx.com/customers) - [Press Releases](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media](https://blog.insight-rx.com/press-releases?section=media) - [Careers](https://www.insight-rx.com/careers) - [Contact](https://www.insight-rx.com/contact-us) --- ![CE marking](https://blog.insight-rx.com/hubfs/ce-mark-white.svg) InsightRX Nova is HITRUST CSF r2 certified, CE marked, and 21 CFR Part 11 compliant. Our quality management, risk management, software lifecycle, and usability engineering processes conform to ISO 13485, IEC 62304, ISO 14971, IEC 62366-1, and IEC 82304-1. InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance. 740-05000-REC-01 · 08/2025 --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://www.insight-rx.com/) 548 Market Street #88083 San Francisco, CA 94104 --- © 2026 InsightRX, Inc. All rights reserved. [Privacy Policy](https://www.insight-rx.com/privacy-policy) Cookie Preferences ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "InsightRX Communications", "url" : "https://blog.insight-rx.com/press-releases/author/insightrx" }, "dateModified" : "2025-12-15T00:26:34.371Z", "datePublished" : "2023-10-04T17:49:00.000Z", "headline" : "InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023", "image" : [ "https://blog.insight-rx.com/hubfs/Copy-of-IDWeek-2023-InsightRX-Twitter-Post-2.png" ], "mainEntityOfPage" : { "@id" : "https://blog.insight-rx.com/press-releases/insightrx-present-multiple-studies-demonstrating-advances-precision-medicine-idweek-2023", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.insight-rx.com/hubfs/insightrx_logo_color%20500%20x%20250-1.png" }, "name" : "InsightRX" } } ```